These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36281546)

  • 1. Blood plasma protein profiles of neuropsychiatric symptoms and related cognitive decline in older people.
    Rabl M; Clark C; Dayon L; Bowman GL; Popp J
    J Neurochem; 2023 Jan; 164(2):242-254. PubMed ID: 36281546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer's Disease.
    Mroczek M; Clark C; Dayon L; Bowman GL; Popp J
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
    Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
    Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
    Ghahremani M; Wang M; Chen HY; Zetterberg H; Smith E; Ismail Z;
    Neurology; 2023 Feb; 100(7):e683-e693. PubMed ID: 36323521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study.
    Sannemann L; Schild AK; Altenstein S; Bartels C; Brosseron F; Buerger K; Cosma NC; Fliessbach K; Freiesleben SD; Glanz W; Heneka MT; Janowitz D; Kilimann I; Kobeleva X; Laske C; Metzger CD; Munk MHJ; Perneczky R; Peters O; Polcher A; Priller J; Rauchmann B; Rösch C; Rudolph J; Schneider A; Spottke A; Spruth EJ; Teipel S; Vukovich R; Wagner M; Wiltfang J; Wolfsgruber S; Duezel E; Jessen F;
    Alzheimers Res Ther; 2020 Oct; 12(1):131. PubMed ID: 33066827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.
    Burhanullah MH; Tschanz JT; Peters ME; Leoutsakos JM; Matyi J; Lyketsos CG; Nowrangi MA; Rosenberg PB
    Am J Geriatr Psychiatry; 2020 Jan; 28(1):64-71. PubMed ID: 31186157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
    Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
    Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals.
    Ng KP; Chiew H; Rosa-Neto P; Kandiah N; Ismail Z; Gauthier S
    Transl Neurodegener; 2021 Mar; 10(1):11. PubMed ID: 33789730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric Inventory in Community-Dwelling Older Adults with Mild Cognitive Impairment and Dementia.
    Nunes PV; Schwarzer MC; Leite REP; Ferretti-Rebustini REL; Pasqualucci CA; Nitrini R; Rodriguez RD; Nascimento CF; Oliveira KC; Grinberg LT; Jacob-Filho W; Lafer B; Suemoto CK
    J Alzheimers Dis; 2019; 68(2):669-678. PubMed ID: 30856109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric symptoms and the outcome of cognitive trajectories in older adults free of dementia: The Mayo Clinic Study of Aging.
    Krell-Roesch J; Syrjanen JA; Machulda MM; Christianson TJ; Kremers WK; Mielke MM; Knopman DS; Petersen RC; Vassilaki M; Geda YE
    Int J Geriatr Psychiatry; 2021 Sep; 36(9):1362-1369. PubMed ID: 33724517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people.
    Clark C; Richiardi J; Maréchal B; Bowman GL; Dayon L; Popp J
    J Neuroinflammation; 2022 May; 19(1):127. PubMed ID: 35643540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
    J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
    Eikelboom WS; van den Berg E; Singleton EH; Baart SJ; Coesmans M; Leeuwis AE; Teunissen CE; van Berckel BNM; Pijnenburg YAL; Scheltens P; van der Flier WM; Ossenkoppele R; Papma JM
    Neurology; 2021 Sep; 97(13):e1276-e1287. PubMed ID: 34413181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.